CCNE1 and PLK1 mediates resistance to palbociclib in HR+/HER2- metastatic breast cancer. Guerrero-Zotano A, Belli S, Zielinski C, Gil-Gil M, et al. Clin Cancer Res 2023 Feb 7:CCR-22-2206. doi: 10.1158/1078-0432.CCR-22-2206.

Read + Share

Amedeo Smart

Independent Medical Education

Guerrero-Zotano A, Belli S, Zielinski C, Gil-Gil M, et al. CCNE1 and PLK1 mediates resistance to palbociclib in HR+/HER2- metastatic breast cancer. Clin Cancer Res 2023 Feb 7:CCR-22-2206. doi: 10.1158/1078-0432.CCR-22-2206.
PMID: 36749874